Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
Dr Tim Mitchell, CEO of Sareum, commented:
"Sareum continues to advance the preclinical development of its proprietary dual TYK2/JAK1 inhibitor programmes. We are close to completing the preclinical development of SDC-1801 with the aim of starting the clinical development of this novel compound in the second half of 2022. This is clearly a very important milestone for the Company. In addition, the early preclinical results we have seen with SDC-1801 in our Covid-19 programme suggest that it may have potential to address the hyper-inflammatory response that some patients experience, and we are looking at the next steps to advance development in this indication. We are particularly pleased to have raised substantial additional funding that will be deployed to advance these programmes into clinical development and build a robust data package that will add momentum to our ongoing partnering activities for these exciting and differentiated assets.
"Furthermore, the possibility that clinical combination studies of SRA737 could be initiated by Sierra in the first half of 2022 is very encouraging and would represent a significant advance in the development of the SRA737 programme. We look forward to further updates on the clinical development of this candidate as the programme progresses."
waning immunity and booster vaccination stalling, as our infection and death rate in the UK is rising, far above many other European countries.....come on SAR, you seeminly have the answer, let's see you make history!
Here he is, hear nothing at all from you classic123 when on an upward trend, not a peep, then when we move down it's constant bashing post. You could not be more transparent to the seasoned invester, unfortunately some newbies will listen to naively take on board your rubbish
No not the MM's
...Your own Emotions and impatience. They often cloud your judgement and make the valid reasons for continued investment hazy, even when the all positives of why you invested are unchanged. The MM's use this to make money
This is the most important part of share dealing that i have learnt over the years.
They don’t worry about a few percent here and there when they investing for returns of 10x…20x…30x…40x
Being that dense won’t get you far in investing world. Learn quickly
These prices are a gift for anyone buying in / topping up
Follow the science and HNWI’s
So just got through to Halifax and they have informed me it's all sky broadband customers who can't get on, and they have no idea why but are in contact now trying to sort the issue out. Tried 4G on phone and i can get on just fine. Advise to anyone with broadband through sky, have a back up plan if this should happen again in the future, you wouldn't want this if big news drops!
I still can't on, tried multiple other sites and all fine, definitely a problem with them. Last time this happened news dropped on another share i'm in and lost out on following through with a plan of action which would gained me thousands!
https://thesecretofthetarot.com/numerology-number-888/
…well let’s hope so ;)
If we get your 30 - 50 bagger Thoth, maybe we will be on this list one day, in the not too distant future hopefully
https://en.wikipedia.org/wiki/List_of_largest_pharmaceutical_mergers_and_acquisitions
A close runner up would also be quite alright for most i'm sure. Either way it could not be more obvious the price will continue to head northwards, just a question of how far, and with what information and events we get there to take us there, with soooo much in the pipeline.